Targeting innate immunity for neurodegenerative disorders of the central nervous system
about
REAC technology modifies pathological neuroinflammation and motor behaviour in an Alzheimer's disease mouse modelThe Alzheimer's disease transcriptome mimics the neuroprotective signature of IGF-1 receptor-deficient neurons.Microglia-targeted stem cell therapies for Alzheimer disease: A preclinical data review.Comparative Analysis of Protein Tyrosine Phosphatases Regulating Microglial Activation.Innate Immunity Stimulation via Toll-Like Receptor 9 Ameliorates Vascular Amyloid Pathology in Tg-SwDI Mice with Associated Cognitive Benefits.Interactions between integrase inhibitors and human arginase 1.Combination therapy with octyl gallate and ferulic acid improves cognition and neurodegeneration in a transgenic mouse model of Alzheimer's disease.Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer's disease and other neurodegenerative diseases.A state of delirium: Deciphering the effect of inflammation on tau pathology in Alzheimer's disease.The Role of Microglia in the Etiology and Evolution of Chronic Traumatic Encephalopathy.Wnt/TLR Dialog in Neuroinflammation, Relevance in Alzheimer's Disease.The Role of Microglia in Retinal Neurodegeneration: Alzheimer's Disease, Parkinson, and Glaucoma.Calcineurin/NFAT Signaling in Activated Astrocytes Drives Network Hyperexcitability in Aβ-Bearing Mice.Live imaging of the innate immune response in neonates reveals differential TLR2 dependent activation patterns in sterile inflammation and infection.Alleviation of Microglial Activation Induced by p38 MAPK/MK2/PGE2 Axis by Capsaicin: Potential Involvement of other than TRPV1 Mechanism/s.iPSC-Derived Human Microglia-like Cells to Study Neurological Diseases.The Amygdala as a Locus of Pathologic Misfolding in Neurodegenerative Diseases.Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease.Let's make microglia great again in neurodegenerative disorders.Inducible and reversible phenotypes in a novel mouse model of Friedreich's Ataxia.Increased Neuronal Differentiation of Neural Progenitor Cells Derived from Phosphovimentin-Deficient Mice.Traumatic Brain Injury and Alzheimer's Disease: The Cerebrovascular Link.TNFα and IL-1β but not IL-18 Suppresses Hippocampal Long-Term Potentiation Directly at the Synapse.Deconvolution of Human Brain Cell Type Transcriptomes Unraveled Microglia-Specific Potential Biomarkers.URMC-099 facilitates amyloid-β clearance in a murine model of Alzheimer's disease.Phosphatidyl-Inositol-3 Kinase Inhibitors Regulate Peptidoglycan-Induced Myeloid Leukocyte Recruitment, Inflammation, and Neurotoxicity in Mouse Brain.Direct and indirect pro-inflammatory cytokine response resulting from TC-83 infection of glial cells
P2860
Q30371534-1F07C4CA-0783-4363-97DC-8C74A8EB93D7Q36396128-16EA9683-30DB-4D6D-8A31-A82FD432934BQ36413131-1EBB06DB-0106-4898-81B0-E0E73BDDC323Q37368903-0A4B7C6A-7A71-4AE0-9206-AA3494785304Q37630548-489CB7FE-44D8-4412-97BA-21AE951B20BAQ38708124-EC35907E-7E47-4311-AB65-8B728000C251Q38781934-12550332-11DF-48D0-B702-2265C7F90B06Q38915171-E769F05F-B81C-40D9-8E65-ECDD25BD9705Q39039980-57A5A4AA-C193-475C-8615-A7B846E056C5Q39149587-97661E3D-C124-4005-8077-7E643517CDB1Q39175449-E61E3425-CB19-4B93-A87E-284CEDBE46C8Q39449147-89192A2F-B9D9-4DA5-AB55-A9D212104774Q40179990-4B740317-F181-4685-A3BA-5B85342A321CQ40185660-C0BBE194-95BA-4B56-A986-09458216FA6FQ41918377-C6014DC7-A8F6-40CF-A254-A37A5B6C41A2Q46001503-79680DF0-1430-44E9-9284-A58A2385CF3AQ46251905-AD251655-6819-4C7C-A46F-0B6D6E950A4BQ46293996-7092B136-A0EB-4D7B-9FE6-88806F5DFBD3Q46926746-0A8C99D3-696F-4D92-B5E4-1EC2372371DAQ47134420-4A86A87B-FFC4-4AF8-ABC1-AED495C94B01Q47611475-2CD27882-F7EB-428D-A456-E3CC8163E640Q49359599-F92328DF-A851-43F0-8BC5-306A8713DAFDQ52331413-C9C0B751-E724-4BF8-A052-7302118D78A8Q54979169-F16CE75E-BDE0-44E6-B70C-23F4B4842AF7Q54979695-1285A2ED-6C1B-4233-85B3-4E099A59051CQ54979894-4134304C-CBAD-4488-9F6E-CBD663E41307Q58766769-194B199F-F775-4701-B471-D991F646580C
P2860
Targeting innate immunity for neurodegenerative disorders of the central nervous system
description
2016 nî lūn-bûn
@nan
2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Targeting innate immunity for neurodegenerative disorders of the central nervous system
@ast
Targeting innate immunity for neurodegenerative disorders of the central nervous system
@en
Targeting innate immunity for neurodegenerative disorders of the central nervous system
@nl
type
label
Targeting innate immunity for neurodegenerative disorders of the central nervous system
@ast
Targeting innate immunity for neurodegenerative disorders of the central nervous system
@en
Targeting innate immunity for neurodegenerative disorders of the central nervous system
@nl
prefLabel
Targeting innate immunity for neurodegenerative disorders of the central nervous system
@ast
Targeting innate immunity for neurodegenerative disorders of the central nervous system
@en
Targeting innate immunity for neurodegenerative disorders of the central nervous system
@nl
P2093
P2860
P50
P3181
P356
P1476
Targeting innate immunity for neurodegenerative disorders of the central nervous system
@en
P2093
Alon Monsonego
Bruce Lamb
Daniel C Lee
Donovan Low
Florent Ginhoux
Gary Landreth
Katrin I Andreasson
Kazuyuki Takata
Leslie A Sandusky
Linda J Van Eldik
P2860
P304
P3181
P356
10.1111/JNC.13667
P407
P50
P577
2016-09-01T00:00:00Z